Show/Hide Menu

MorphoSys's vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Events

03. Thu
August

Publication of Half-Year Report 2017

07. Tue
November

Publication of Third Quarter Interim Statement 2017

Presentations

06/22/2017
dbAccess Berlin Conference
Berlin; Germany
06/05/2017
Investor Event ASCO 2017
Chicago, Illinois, USA
05/22/2017
UBS Global Healthcare Conference
New York, USA
05/04/2017
Q1 2017 Financial Results
Planegg, Germany
04/19/2017
10th Kempen Life Sciences Conference
Amsterdam, Netherlands

Media and investors

Anke Linnartz

Vice President, Head of Corporate Communications and IR

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact
LinkedIn-Profile

Alexandra Goller

Senior Manager Corporate Communications and Investor Relations

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact
LinkedIn-Profile

Jochen Orlowski

Associate Director Corporate Communications and Investor Relations

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact